Cautionary Statements About Forward-Looking Statements



This report contains certain estimates and forward-looking statements within the
meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and
Section 27A of the Securities Act of 1933, as amended, which are intended to be
covered by the safe harbor provisions for forward-looking statements contained
in the Private Securities Litigation Reform Act of 1995, and may be identified
by their use of words like "plans," "expects," "will," "anticipates,"
"believes," "intends," "projects," "estimates" or other words of similar
meaning. All statements that address expectations or projections about the
future, including statements about Corteva's strategy for growth, product
development, regulatory approval, market position, anticipated benefits of
recent acquisitions, timing of anticipated benefits from restructuring actions,
outcome of contingencies, such as litigation and environmental matters,
expenditures, and financial results, as well as expected benefits from, the
separation of Corteva from DuPont, are forward-looking statements.

Forward-looking statements and other estimates are based on certain assumptions
and expectations of future events which may not be accurate or realized.
Forward-looking statements and other estimates also involve risks and
uncertainties, many of which are beyond Corteva's control. While the list of
factors presented below is considered representative, no such list should be
considered to be a complete statement of all potential risks and uncertainties.
Unlisted factors may present significant additional obstacles to the realization
of forward-looking statements. Consequences of material differences in results
as compared with those anticipated in the forward-looking statements could
include, among other things, business disruption, operational problems,
financial loss, legal liability to third parties and similar risks, any of which
could have a material adverse effect on Corteva's business, results of
operations and financial condition. Some of the important factors that could
cause Corteva's actual results to differ materially from those projected in any
such forward-looking statements include: (i) failure to successfully develop and
commercialize Corteva's pipeline; (ii) effect of competition and consolidation
in Corteva's industry; (iii) failure to obtain or maintain the necessary
regulatory approvals for some Corteva's products; (iv) failure to enforce
Corteva's intellectual property rights or defend against intellectual property
claims asserted by others; (v) effect of competition from manufacturers of
generic products; (vi) impact of Corteva's dependence on third parties with
respect to certain of its raw materials or licenses and commercialization; (vii)
costs of complying with evolving regulatory requirements and the effect of
actual or alleged violations of environmental laws or permit requirements;
(viii) effect of the degree of public understanding and acceptance or perceived
public acceptance of Corteva's biotechnology and other agricultural products;
(ix) effect of changes in agricultural and related policies of governments and
international organizations; (x) effect of industrial espionage and other
disruptions to Corteva's supply chain, information technology or network
systems; (xi) competitor's establishment of an intermediary platform for
distribution of Corteva's products; (xii) effect of volatility in Corteva's
input costs; (xiii) failure to raise capital through the capital markets or
short-term borrowings on terms acceptable to Corteva; (xiv) failure of Corteva's
customers to pay their debts to Corteva, including customer financing programs;
(xv) failure to realize the anticipated benefits of the internal reorganizations
taken by DowDuPont in connection with the spin-off of Corteva, including failure
to benefit from significant cost synergies; (xvi) risks related to the
indemnification obligations of legacy EID liabilities in connection with the
separation of Corteva; (xvii) increases in pension and other post-employment
benefit plan funding obligations; (xviii) effect of compliance with laws and
requirements and adverse judgments on litigation; (xix) risks related to
Corteva's global operations; (xx) effect of climate change and unpredictable
seasonal and weather factors; (xxi) effect of counterfeit products; (xxii)
failure to effectively manage acquisitions, divestitures, alliances and other
portfolio actions; (xxiii) risks related to non-cash charges from impairment of
goodwill or intangible assets; (xxiv) risks related to COVID-19; (xxv) risks
related to oil and commodity markets; and (xxvi) other risks related to the
Separation from DowDuPont.

Additionally, there may be other risks and uncertainties that Corteva is unable
to currently identify or that Corteva does not currently expect to have a
material impact on its business. Where, in any forward-looking statement or
other estimate, an expectation or belief as to future results or events is
expressed, such expectation or belief is based on the current plans and
expectations of Corteva's management and expressed in good faith and believed to
have a reasonable basis, but there can be no assurance that the expectation or
belief will result or be achieved or accomplished. Corteva disclaims and does
not undertake any obligation to update or revise any forward-looking statement,
except as required by applicable law. A detailed discussion of some of the
significant risks and uncertainties which may cause results and events to differ
materially from such forward-looking statements is included in the section
titled "Risk Factors" (Part II, Item 1A of this quarterly report on Form 10-Q).

                                       41

--------------------------------------------------------------------------------


  Table of Contents

Recent Developments

COVID-19 Pandemic
On March 11, 2020, the World Health Organization ("WHO") declared the novel
coronavirus disease ("COVID-19") a pandemic. Since the early days of the
coronavirus outbreak, Corteva has taken steps to help protect the health and
safety of its employees, customers, vendors, and stakeholders. Corteva has
engaged crisis management teams at the country, regional and global level, and
its Integrated Health Services Pandemic & Infectious Disease Planning Team has
been monitoring the situation and developing guidelines and protocols that have
been communicated to all of its employees globally.

Overwhelmingly, countries and U.S. states have considered agriculture an
"essential business"; therefore, Corteva is not subject to many of the
restrictions imposed by the government, particularly on non-essential
businesses, which, in certain cases, includes ordering businesses to close or
limit operations or people to stay at home. While the company's business has
experienced some localized operating disruptions, particularly around sourcing
and logistics, these disruptions have been temporary and have not materially
impacted the company's financial results. Additionally, the company has
implemented mitigating strategies to limit the impact of supply chain
disruptions, including leveraging the company's ability to use a multi-sourcing
strategy and source key raw materials from multiple suppliers and countries.
Furthermore, the company implemented remote work arrangements for non-essential
employees and restricted business travel effective mid-March, and to date, these
arrangements have not materially affected the company's ability to maintain its
business operations, including the operation of financial reporting systems,
internal control over financial reporting, and disclosure controls and
procedures.

The global health crisis caused by COVID-19 and the related government actions
and stay at home orders have negatively impacted economic activity and increased
political instability across the globe. The company has observed declining
demand and price reductions in the oil and gas sector as business and consumer
activity decelerates across the globe, which has impacted the price of corn.
When COVID-19 is demonstrably contained, the company anticipates a rebound in
economic activity, depending on the rate, pace, and effectiveness of the
containment efforts deployed by various national, state, and local governments.
Corteva will continue to actively monitor the situation and may take further
actions altering its business operations that it determines are in the best
interests of its stakeholders, or as required by federal, state, or local
authorities. It is not clear what the potential effects any such alterations or
modifications may have on the company's business, including the effects on its
customers, employees, and prospects, or on its financial results for the
remainder of fiscal 2020 and beyond. With the increasing uncertainty in global
markets, the company will continue to monitor various factors that could impact
mid-term forecasted cash flows of the business, including, but not limited to
currency fluctuations, expectations of future planted area (as influenced by
consumer demand and ethanol markets) and relative commodity prices, which could
trigger an assessment of recoverability of goodwill and other indefinite and
definite-lived intangible assets.

Execute to Win Productivity Program
During the first quarter of 2020, Corteva approved restructuring actions
designed to improve productivity through optimizing certain operational and
organizational structures primarily related to the Execute to Win Productivity
Program. As a result of these actions, the company expects to record total
pre-tax restructuring charges of approximately $185 million, comprised of
approximately $125 million of asset related charges (of which $30 million
relates to asset retirement obligations), and $60 million of severance and
related benefit costs. The restructuring actions associated with this charge are
expected to be substantially complete in 2020.

During the three months ended March 31, 2020, the company recorded pre-tax
charges of $63 million, recognized in restructuring and asset related charges -
net in the company's interim Consolidated Statement of Operations comprised of
$21 million of asset related charges and $42 million of severance and related
benefit costs.

Future cash payments related to this charge are anticipated to be approximately
$90 million, primarily related to the payment of severance and related benefits
and asset retirement obligations. The company expects $130 million of savings to
be achieved on a run rate basis by 2023.

Share Buyback Plan
On June 26, 2019, Corteva, Inc. announced that its Board of Directors authorized
a $1 billion share repurchase program to purchase Corteva, Inc.'s common stock,
par value $0.01 per share, without an expiration date. The program is expected
to be completed in three years. The timing, price and volume of purchases will
be based on market conditions, relevant securities laws and other factors.
During the three months ended March 31, 2020, the company purchased and retired
1,865,000 shares in the open market for a total cost of $50 million, with the
last purchase completed on March 10, 2020.


                                       42

--------------------------------------------------------------------------------

Table of Contents

Overview

The following is a summary of results from continuing operations for the three months ended March 31, 2020:

• The company reported net sales of $3,956 million, up 16 percent versus the

same quarter last year, reflecting a 17 percent increase in volume and a 3

percent increase in local price, partially offset by a 3 percent decline


       in currency and a 1 percent impact from portfolio.


• Cost of goods sold ("COGS") totaled $2,269 million in the first quarter of


       2020, up from $2,211 million in the first quarter of 2019, primarily
       driven by increased volumes. The three months ended March 31, 2019
       included $205 million of amortization of inventory step-up.



•      Restructuring and asset related charges - net were $70 million in the

first quarter of 2020, an increase from $61 million in the first quarter


       2019.


• There were no integration and separation costs in the first quarter of


       2020, as compared to $212 million in the first quarter of 2019.


• Income from continuing operations after income taxes was $281 million, as


       compared to a loss of $(184) million in the same quarter last year.


• Operating EBITDA was $794 million, up from $518 million for the three

months ended March 31, 2019, as volume increases from strong early demand

in North America and Europe, price increases for new products and ongoing


       cost-improvement actions more than offset currency headwinds. Refer to
       page 51 for further discussion of the company's Non-GAAP financial
       measures.


• The company realized cost synergies of approximately $70 million for the

three months ended March 31, 2020.

In addition to the financial highlights above, the following events occurred during or subsequent to the first quarter of 2020:

• The company repurchased $50 million of shares as part of the $1 billion


       share repurchase program announced in the second quarter of 2019.


• The company announced it is suspending its full year 2020 Corporate

Outlook in light of the COVID-19 crisis and volatility it is creating in


       the global markets. Refer to page 60 for further discussion.




                                       43

--------------------------------------------------------------------------------


  Table of Contents

Selected Financial Data
                                                               Three Months Ended
In millions, except per share amounts                               March 31,
                                                               2020           2019
Net sales                                                 $      3,956    $     3,396

Cost of goods sold                                        $      2,269    $     2,211
Percent of net sales                                                57 %           65 %

Research and development expense                          $        280    $ 

299


Percent of net sales                                                 7 %    

9 %



Selling, general and administrative expenses              $        757    $ 

735


Percent of net sales                                                19 %    

22 %



Effective tax rate on continuing operations                       31.1 %    

26.7 %

Income (loss) from continuing operations after income taxes

$        281    $ 

(184 )

Income (loss) from continuing operations available to Corteva common stockholders

$        271    $ 

(192 )

Basic earnings (loss) per share of common stock from continuing operations

$       0.36    $     (0.26 )
Diluted earnings (loss) per share of common stock from
continuing operations                                     $       0.36    $     (0.26 )




                                       44

--------------------------------------------------------------------------------


  Table of Contents

Results of Operations

Net Sales
Net sales were $3,956 million and $3,396 million for the three months ended
March 31, 2020 and 2019, respectively. The increase was primarily driven by a 17
percent increase in volume and a 3 percent increase in price, partially offset
by a 3 percent decrease in currency and a 1 percent impact from portfolio.
Volume gains were primarily driven by earlier seed deliveries due to improved
weather conditions and the anticipated recovery of planted area in North
America, strong early demand in EMEA due to perceived supply concerns from
COVID-19, and strong demand for new products in crop protection. Pricing gains
were largely driven by increased pricing to offset currency in Latin America and
improved mix from new products in both North America and Latin America.
Unfavorable currency impacts were primarily driven by the Brazilian Real and the
European Euro. The portfolio impact was due to prior year divestitures in North
America and Asia Pacific.
                         Three Months Ended
                              March 31,
                      2020                 2019
                Net Sales            Net Sales
               ($ Millions)    %    ($ Millions)    %
Worldwide     $       3,956  100 % $       3,396  100 %
North America         1,765   45 %         1,392   41 %
EMEA                  1,467   37 %         1,364   40 %
Latin America           434   11 %           365   11 %
Asia Pacific            290    7 %           275    8 %


                             Q1 2020 vs. Q1 2019                     Percent Change Due To:
                              Net Sales Change       Local Price &                              Portfolio /
$ In millions                    $            %       Product Mix     Volume      Currency         Other
North America             $         373        27 %        2 %            26 %         -  %         (1 )%
EMEA                                103         8 %        2 %             9 %        (3 )%          -  %
Latin America                        69        19 %       11 %            19 %       (11 )%          -  %
Asia Pacific                         15         5 %        2 %             8 %        (3 )%         (2 )%
Total                     $         560        16 %        3 %            17 %        (3 )%         (1 )%



Cost of Goods Sold
COGS was $2,269 million and $2,211 million for the three months ended March 31,
2020 and 2019, respectively. The increase was primarily driven by higher volumes
in both seed and crop protection and higher unit costs for crop protection,
partially offset by favorable product mix in seed, ongoing cost synergies and
productivity, and the lack of amortization of inventory step-up for the three
months ended March 31, 2020, as compared to $205 million recognized for the
three months ended March 31, 2019.

COGS as a percentage of net sales was 57 percent and 65 percent for the three
months ended March 31, 2020 and 2019, respectively. The amortization of
inventory step-up was 6 percent of net sales for the three months ended March
31, 2019.

Research and Development Expense
R&D expense was $280 million (7 percent of net sales) and $299 million (9
percent of net sales) for the three months ended March 31, 2020 and 2019,
respectively. The decrease was driven primarily driven by ongoing cost synergies
and productivity efforts and actions taken to assess and reduce spending in the
first quarter of 2020.

Selling, General and Administrative Expenses
SG&A expenses were $757 million (19 percent of net sales) and $735 million (22
percent of net sales) for the three months ended March 31, 2020 and 2019,
respectively. The increase was primarily driven by higher commissions and
selling expenses due to higher volumes and increases in bad debt expense,
partially offset by the settlement of a legal matter in the prior year, ongoing
cost synergies and productivity efforts, and lower promotion and advertising
expense.


                                       45

--------------------------------------------------------------------------------

Table of Contents



Amortization of Intangibles
Intangible asset amortization was $163 million and $101 million for the three
months ended March 31, 2020 and 2019, respectively. The increase was primarily
driven by amortization of germplasm assets, which changed from an indefinite
lived intangible asset to definite lived with a useful life of 25 years in the
fourth quarter of 2019. See Note 12 - Other Intangible Assets, to the interim
Consolidated Financial Statements for additional information.

Restructuring and Asset Related Charges - Net
Restructuring and asset related charges - net were $70 million and $61 million
for the three months ended March 31, 2020 and 2019, respectively. The charges in
the first quarter of 2020 primarily related to severance and related benefit
costs and asset related charges under the Execute to Win Productivity Program,
and there were no cash payments made during the three months ended March 31,
2020. The charges in the first quarter of 2019 primarily related to asset
related charges, contract termination charges, and severance and related benefit
costs under the DowDuPont Cost Synergy Program.

In addition, during the three months ended March 31, 2020, the company
recognized $10 million in restructuring and asset related charges, net in the
interim consolidated statement of operations, from non-cash accelerated prepaid
royalty amortization expense related to Roundup Ready 2 Yield® and Roundup Ready
2 Xtend® herbicide tolerance traits.

See Note 5 - Restructuring and Asset Related Charges, Net, to the interim Consolidated Financial Statements for additional information.



Integration and Separation Costs
Integration and separation costs were $212 million for the three months ended
March 31, 2019. These costs primarily consisted of financial advisory,
information technology, legal, accounting, consulting, and other professional
advisory fees associated with the preparation and execution of activities
related to the Distributions and the integration of EID's Pioneer and Crop
Protection businesses with DAS.

Other Income - Net
Other income - net was $1 million and $31 million for the three months ended
March 31, 2020 and 2019, respectively. The decrease was primarily due to higher
net exchange losses and higher losses on asset sales, including a $53 million
loss related to the expected sale of the La Porte site, for which the company
signed an agreement during the three months ended March 31, 2020, as compared to
a $24 million loss related to DAS's sale of a joint venture related to synergy
actions in the three months ended March 31, 2019. This decrease was partially
offset by an increase in non-operating pension and other post employment benefit
credits.

The company routinely uses forward exchange contracts to offset its net
exposures, by currency denominated monetary assets and liabilities of its
operations. The objective of this program is to maintain an approximately
balanced position in foreign currencies in order to minimize, on an after-tax
basis, the effects of exchange rate changes. The net pre-tax exchange gains and
losses are recorded in other income - net and the related tax impact is recorded
in provision for (benefit from) income taxes on continuing operations in the
interim Consolidated Statement of Operations.

The after-tax net exchange losses were $(78) million and $(33) million for the
three months ended March 31, 2020 and March 31, 2019, respectively. The increase
in net exchange loss was primarily driven by currency devaluations for the
Ukrainian Hryvnia, Argentine Peso and the Mexican Peso.

See Note 7 - Supplementary Information, to the interim Consolidated Financial Statements for additional information.



Interest Expense
Interest expense was $10 million and $59 million for the three months ended
March 31, 2020 and 2019, respectively. The change was primarily driven by lower
average long-term debt balances as a result of the redemption/repayment
transactions in the second quarter of 2019.

Provision for (Benefit from) Income Taxes on Continuing Operations
The company's provision for income taxes on continuing operations was $127
million for the three months ended March 31, 2020 on pre-tax income from
continuing operations of $408 million, resulting in an effective tax rate of
31.1 percent.  The effective tax rate was unfavorably impacted by the tax impact
of certain net exchange losses recognized on the re-measurement of the net
monetary asset positions which were not tax-deductible in their local
jurisdictions, as well as tax charges related to the issuance of stock-based
compensation.


                                       46

--------------------------------------------------------------------------------

Table of Contents



The company's benefit from income taxes on continuing operations was $(67)
million for the three months ended March 31, 2019 on a pre-tax loss from
continuing operations of $(251) million, resulting in an effective tax rate of
26.7 percent. The effective tax rate was favorably impacted by a tax benefit of
$102 million related to an internal legal entity restructuring associated with
the Internal Reorganizations. The effective tax rate was unfavorably impacted
non-tax-deductible amortization of the fair value step-up in inventories as a
result of the Merger, as well as the impact of integration and separation costs,
including a $32 million tax charge associated with U.S. state blended tax rate
changes. Other unfavorable effective tax rate impacts included the tax impact of
certain net exchange losses recognized on the re-measurement of the net monetary
asset positions which were not tax-deductible in their local jurisdictions, as
well as geographic mix of earnings.

Income from Discontinued Operations After Tax
Income from discontinued operations after tax was $1 million and $360 million
for the three months ended March 31, 2020 and 2019, respectively. The three
months ended March 31, 2019 reflects the operations of EID ECP and the EID
Specialty Product Entities.  Refer to Note 3 - Divestitures and Other
Transactions for further information.

EID Analysis of Operations
As discussed in Note 1 - Basis of Presentation, to the EID Consolidated
Financial Statements, EID is a subsidiary of Corteva, Inc. and continues to be a
reporting company, subject to the requirements of the Exchange Act. The below
relates to EID only and is presented to provide an Analysis of Operations, only
for the differences between EID and Corteva, Inc.

Interest Expense
EID's interest expense was $42 million and $59 million for the three months
ended March 31, 2020 and 2019, respectively, and driven by the items noted on
page 46, under the header "Interest Expense", partially offset by interest
expense incurred on the related party loan between EID and Corteva, Inc. See
Note 2 - Related Party Transactions, to the EID Consolidated Financial
Statements for further information.

Provision for (Benefit from) Income Taxes on Continuing Operations
For the three months ended March 31, 2020, EID had an effective tax rate of 31.6
percent on pre-tax income from continuing operations of $376 million, driven by
the items noted on page 46, under the header "Provision for (Benefit from)
Income Taxes on Continuing Operations" and a tax benefit related to the interest
expense incurred on the related party loan between EID and Corteva, Inc. See
Note 2 - Related Party Transactions, to the EID Consolidated Financial
Statements for further information.

Corporate Outlook
The overall impact of COVID-19 on the company's consolidated results of
operations for the three months ended March 31, 2020 was not material and was
limited to localized operating disruptions (as previously discussed on page
42).  However, given the economic volatility caused by COVID-19 and related
government actions, the company is suspending the previously issued corporate
outlook  for the full year 2020, included in the company's 2019 Annual Report.
As noted in the Liquidity and Capital Resources discussion, on pages 54 - 56,
and Note 13 -   Short-Term Borrowings, Long-Term Debt and Available Credit
Facilities  , to the interim Consolidated Financial Statements, the company
maintains sufficient access to liquidity via commercial paper markets, $6
billion in revolving credit facilities, and $2 billion in cash and cash
equivalents.  With the increasing uncertainty in global markets, the company
will continue to monitor near-term operating conditions with a focus on business
continuity and any potential adverse effects on the company's financial results
from lower demand for the company's products, such as declines in corn volumes
related to lower corn commodity prices stemming from a drop in the use of corn
for ethanol production, that could trigger an assessment of the recoverability
of goodwill and other indefinite and definite-lived intangible assets.


                                       47

--------------------------------------------------------------------------------

Table of Contents



Supplemental Unaudited Pro Forma Financial Information
The following supplemental unaudited pro forma statements of operations (the
"unaudited pro forma statements of operations") for Corteva give effect to the
Merger, the debt retirement transactions related to paying off or retiring
portions of EID's existing debt liabilities (as discussed in Note 13 -
Short-Term Borrowings, Long-Term Debt and Available Credit Facilities, to the
interim Consolidated Financial Statements), and the separation and distribution
to DowDuPont stockholders of all the outstanding shares of Corteva common stock
as if they had been consummated on January 1, 2016. For the periods presented
below, Corteva's results for all periods prior to the Business Realignment and
Internal Reorganization consist of the combined results of operations for
Historical EID and DAS, and Corteva's results for all periods after the Business
Realignment and Internal Reorganization represent the consolidated balances of
the company. The unaudited pro forma statements of operations below were
prepared in accordance with Article 11 of Regulation S-X, and events that are
not expected to have a continuing impact on the combined results (e.g.,
inventory step-up costs) are excluded. One-time transaction-related costs
incurred prior to, or concurrent with, the closing of the Merger, the debt
redemptions/repayments, and the Corteva Distribution are not included in the
unaudited pro forma combined statements of operations through March 31, 2019.
The unaudited pro forma combined statements of operations do not reflect
restructuring or integration activities or other costs following the separation
and distribution transactions that may be incurred to achieve cost or growth
synergies of Corteva. As no assurance can be made that these costs will be
incurred or the growth synergies will be achieved, no adjustment has been made.

The unaudited pro forma statements of operations have been presented for
informational purposes only and are not necessarily indicative of what Corteva's
results of operations actually would have been had the above transactions been
completed on January 1, 2016. In addition, the unaudited pro forma statements of
operations do not purport to project the future operating results of the
company. The unaudited pro forma statements of operations were based on and
should be read in conjunction with the audited Consolidated Financial Statements
and Notes contained within the company's Annual Report on Form 10-K for the year
ended December 31, 2019.

                                       48

--------------------------------------------------------------------------------

Table of Contents

© Edgar Online, source Glimpses